ESR1 and breast cancer: Estrogen receptor (ER), progesterone receptor (PgR), and human epithelial growth factor receptor 2 (HER2) are recognized as common clinical markers for tumor growth and progression, and indicators for determining appropriate therapy for BC patients [4].